Rasagiline and Pisa syndrome in Parkinson's disease patients

Neurol Sci. 2015 Mar;36(3):485-6. doi: 10.1007/s10072-014-2024-x. Epub 2014 Dec 7.

Authors

Paolo Solla¹, Antonino Cannas, Gianni Orofino, Francesco Marrosu

Affiliation

¹ Movement Disorders Center, Department of Neurology, Policlinico Universitario Monserrato, University of Cagliari, SS 554 Bivio per Sestu, Monserrato, Cagliari, 09042, Italy, paosol29@yahoo.it.

PMID: 25481627
DOI: 10.1007/s10072-014-2024-x

No abstract available

Publication types

Comment

MeSH terms

Antiparkinson Agents / adverse effects*
Dystonia / chemically induced*
Female
Humans
Indans / adverse effects*
Parkinson Disease / drug therapy*

Substances

Antiparkinson Agents
Indans